Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the West.

Background: In Western countries, hepatocellular carcinoma (HCC) in hepatitis B (HBV) patients without cirrhosis was poorly studied. The aim was to describe the characteristics and outcome of HBV-related HCC according to fibrosis stage.

Method: All patients with chronic HBV infection and HCC discussed in a multidisciplinary tumor board between 2007 and 2017 were retrospectively included.

[Management and surveillance of compensated cirrhosis].

Management and surveillance of compensated Cirrhosis. Patients with compensated cirrhosis are now identified early using non-invasive fibrosis tests. Therapeutic advances in hepatology, in particular antiviral agents, have changed their prognosis by dramatically reducing the occurrence of liver complications, whether hepatic decompensation or hepatocellular carcinoma.